Electrophysiological Modulation of Cardiomyocytic Tissue by Transfected Fibroblasts Expressing Potassium Channels
Open Access
- 29 January 2002
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 105 (4), 522-529
- https://doi.org/10.1161/hc0402.102661
Abstract
Background — Traditional pharmacological therapies aiming to modify the abnormal electrophysiological substrate underlying cardiac arrhythmias may be limited by their relatively low efficacy, global cardiac activity, and significant proarrhythmic effects. We suggest a new approach, in which transfected cellular grafts expressing various ionic channels may be used to manipulate the local electrophysiological properties of cardiac tissue. To examine the feasibility of this concept, we tested the hypothesis that transfected fibroblasts expressing the voltage-sensitive potassium channel Kv1.3 can modify the electrophysiological properties of cardiomyocytic cultures. Methods and Results — A high-resolution multielectrode mapping technique was used to assess the electrophysiological and structural properties of primary cultures of neonatal rat ventricular myocytes. The transfected fibroblasts, added to the cardiomyocytic cultures, caused a significant effect on the conduction properties of the hybrid cultures. These changes were manifested by significant reduction in extracellular signal amplitude and by the appearance of multiple local conduction blocks. The location of all conduction blocks correlated with the spatial distribution of the transfected fibroblasts assessed by vital staining. All electrophysiological changes were reversed after the application of Charybdotoxin, a specific Kv1.3 blocker. In contrast, conduction remained uniform in the control hybrid cultures when nontransfected fibroblasts were used. Conclusions — Transfected fibroblasts are able to electrically couple with cardiac myocytes, causing a significant local and reversible modification of the tissue’s electrophysiological properties. More broadly, this study suggests that transfected cellular grafts expressing various ionic channels may be used to modify cardiac excitability, providing a possible future novel cell therapy strategy.Keywords
This publication has 11 references indexed in Scilit:
- Focal modification of electrical conduction in the heart by viral gene transferNature Medicine, 2000
- Action potential propagation failures in long-term recordings from embryonic stem cell-derived cardiomyocytes in tissue culturePflügers Archiv - European Journal of Physiology, 1999
- Overexpression of a human potassium channel suppresses cardiac hyperexcitability in rabbit ventricular myocytesJCI Insight, 1999
- Slow Changes in the Availability of Voltage-gated Ion Channels: Effects on the Dynamics of Excitable MembranesThe Journal of Membrane Biology, 1998
- Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarctionThe Lancet, 1996
- Adenovirus-mediated expression of a voltage-gated potassium channel in vitro (rat cardiac myocytes) and in vivo (rat liver). A novel strategy for modifying excitability.JCI Insight, 1995
- Modeling state-dependent inactivation of membrane currentsBiophysical Journal, 1994
- State-dependent inactivation of the Kv3 potassium channelBiophysical Journal, 1994
- Tetrodotoxin-sensitive Sodium Current in Rat Fetal Ventricular Myocytes - Contribution to the plateau phase of action potentialJournal of Molecular and Cellular Cardiology, 1993
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboNew England Journal of Medicine, 1991